Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
185
-
Total 13F shares, excl. options
-
100,212,572
-
Shares change
-
+3,236,774
-
Total reported value, excl. options
-
$1,902,689,658
-
Value change
-
+$38,904,536
-
Put/Call ratio
-
79.5%
-
Number of buys
-
83
-
Number of sells
-
-110
-
Price
-
$19.00
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2021
269 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q4 2021.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 185 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100,212,572 shares
of 158,835,667 outstanding shares and own 63.1% of the company stock.
Largest 10 shareholders include FMR LLC (20,721,431 shares), VANGUARD GROUP INC (12,091,437 shares), BlackRock Inc. (8,902,165 shares), MAVERICK CAPITAL LTD (6,034,875 shares), STATE STREET CORP (5,824,178 shares), WELLINGTON MANAGEMENT GROUP LLP (4,250,670 shares), Capital World Investors (4,172,153 shares), PICTET ASSET MANAGEMENT SA (2,387,613 shares), GEODE CAPITAL MANAGEMENT, LLC (2,309,837 shares), and RA CAPITAL MANAGEMENT, L.P. (2,210,145 shares).
This table shows the top 185 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.